InstalabOmega-3 Index Plus
Should you take a Omega-3 Index Plus test?
This test is most useful if any of these apply to you.
4 Biomarkers Included
- Omega-3 IndexThe core marker, showing the combined level of two marine omega-3 fats (EPA and DHA) in your red blood cell walls. It reflects months of diet and is the most studied fatty acid tied to heart risk.A low level near or below 4 percent points to inadequate omega-3 status and a less favorable long-term heart risk profile.
- AA:EPACompares a common omega-6 fat (arachidonic acid) with the omega-3 EPA. Because they compete to make pro- and anti-inflammatory signals, this ratio reflects that fat balance, most tellingly when inflammation is already elevated.A high ratio suggests your fat balance favors inflammation, even when total omega-3 is not severely low.
- Omega-6:Omega-3Weighs all omega-6 fats against all omega-3 fats to capture your broader dietary fat pattern. It adds context but is less specific than measuring EPA and DHA directly.A high ratio usually signals too little omega-3 rather than simply too much omega-6.
- Trans Fat IndexMeasures industrially altered (trans) fats lodged in your cell walls. These fats worsen cholesterol and track with heart disease, so lower is better.An elevated level flags a diet still heavy in processed or fried foods, regardless of your omega-3 status.
About Omega-3 Index Plus
The fats you eat slowly become part of you. Over months, the omega-3s, omega-6s, and trans fats in your diet get built into the walls of your red blood cells, where they leave a lasting record of your fat balance. This panel reads that record.
A food diary asks what you think you ate. This panel measures what actually reached your tissues, which is often very different. It gives you four related numbers that together describe your long-term fat balance and how it may relate to heart and inflammation risk.
What This Panel Reveals
Red blood cells (the oxygen-carrying cells in your blood, often shortened to RBCs) live for about three to four months. The fats in their walls reflect roughly the last 90 to 120 days of your diet, not your last meal. That makes this a stable, long-term picture, and these membrane measurements also vary less from day to day than standard blood-fat tests.
The anchor of the panel is the Omega-3 Index, the combined amount of two marine omega-3 fats (called EPA and DHA) in your red blood cell walls. Higher levels track with lower long-term heart risk in large population studies. Most adults in North America and Europe sit well below the commonly cited target, with national averages often between roughly 4 and 6 percent.
The other three markers describe balance. The AA:EPA ratio compares a common omega-6 fat (arachidonic acid) against the omega-3 EPA, since these two compete to make signaling molecules that either promote or calm inflammation. The omega-6 to omega-3 ratio captures your broader dietary fat pattern, and the Trans Fat Index measures exposure to industrially altered fats that worsen cholesterol and track with heart disease.
How to Read Your Results Together
No single number tells the whole story. The value of this panel is in the pattern across all four markers, which can separate a simple omega-3 shortfall from a broader diet-quality problem.
| Pattern | What It Suggests |
|---|---|
| Low Omega-3 Index with high AA:EPA | Too little marine omega-3 and a fat balance tilted toward inflammation. The clearest signal to raise EPA and DHA intake. |
| Low Omega-3 Index with high omega-6 to omega-3 | Low fish or omega-3 intake against a background diet heavy in omega-6 oils. The main fix is usually more omega-3, not less omega-6. |
| Healthy Omega-3 Index with elevated Trans Fat Index | Good omega-3 status but continued exposure to processed or fried foods that still carry heart risk. |
When the overall pattern looks unfavorable, the usual driver is inadequate EPA and DHA rather than an excess of omega-6. That is why the omega-6 to omega-3 ratio is best read as supporting context, and the Omega-3 Index as the number to act on first.
What to Do with Your Results
If your Omega-3 Index falls in the lower range (near or below 4 percent), the practical response is to raise EPA and DHA through oily fish or a supplement. Response varies widely between people at the same dose, so the amount that moves one person into the target range may do little for another. This is exactly why measuring beats guessing. High-dose omega-3 supplements have also been linked to a small increase in the risk of atrial fibrillation (an irregular heartbeat), so discuss dosing with your clinician before taking large amounts.
Because red blood cells turn over slowly, wait about three to four months after a sustained change before retesting, when the new level has largely settled. An earlier check at 4 to 8 weeks can confirm you are trending in the right direction. To round out the heart picture, pair this panel with markers of particle risk and inflammation, since fatty acid status is one input among several.
In large studies, higher membrane omega-3 levels line up with better outcomes. People with the highest levels (above about 6.8 percent) had a 34 percent lower risk of death from any cause and a 39 percent lower risk of developing cardiovascular disease (heart and blood vessel disease, or CVD) than those with the lowest levels (below about 4.2 percent). Separately, moving from 4 percent to 8 percent was estimated to lower fatal coronary heart disease risk by roughly 30 percent.
When Results Can Be Misleading
Acute illness and strong inflammation can shift the fats in cell membranes on their own, so results drawn during a serious illness may not reflect your usual diet. Age, genetics, and smoking also influence your levels. And because laboratory methods are not fully standardized, values from different labs are not always directly comparable, which matters most if you switch providers between tests.
One more caution: these ratios are not a stand-alone inflammation test. A high omega-6 reading does not automatically mean high inflammation, since omega-6 fats are not uniformly harmful. Read the panel as a fat-balance profile, not as a diagnosis.